Cargando…
The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding
SIMPLE SUMMARY: Chlamydia is a major pathogen of the Australian marsupial, the koala (Phascolarctos cinereus). One approach to improving this situation is to develop a vaccine. Human Chlamydia research suggests that an effective anti-chlamydial response will involve a balance between a cell-mediated...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913230/ https://www.ncbi.nlm.nih.gov/pubmed/33546104 http://dx.doi.org/10.3390/ani11020380 |
_version_ | 1783656757478817792 |
---|---|
author | Quigley, Bonnie L Timms, Peter |
author_facet | Quigley, Bonnie L Timms, Peter |
author_sort | Quigley, Bonnie L |
collection | PubMed |
description | SIMPLE SUMMARY: Chlamydia is a major pathogen of the Australian marsupial, the koala (Phascolarctos cinereus). One approach to improving this situation is to develop a vaccine. Human Chlamydia research suggests that an effective anti-chlamydial response will involve a balance between a cell-mediated Th1 response and a humoral Th2 responses, involving systemic IgG and mucosal IgA. Characterization of koalas with chlamydial disease suggests that increased expression for similar immunological pathways and monitoring of koalas’ post-vaccination can be successful and subsequently lead to improved vaccines. These findings offer optimism that a chlamydial vaccine for wider distribution to koalas is not far off. ABSTRACT: Chlamydia is a significant pathogen for many species, including the much-loved Australian marsupial, the koala (Phascolarctos cinereus). To combat this situation, focused research has gone into the development and refinement of a chlamydial vaccine for koalas. The foundation of this process has involved characterising the immune response of koalas to both natural chlamydial infection as well as vaccination. From parallels in human and mouse research, it is well-established that an effective anti-chlamydial response will involve a balance of cell-mediated Th1 responses involving interferon-gamma (IFN-γ), humoral Th2 responses involving systemic IgG and mucosal IgA, and inflammatory Th17 responses involving interleukin 17 (IL-17) and neutrophils. Characterisation of koalas with chlamydial disease has shown increased expression within all three of these major immunological pathways and monitoring of koalas’ post-vaccination has detected further enhancements to these key pathways. These findings offer optimism that a chlamydial vaccine for wider distribution to koalas is not far off. Recent advances in marsupial genetic knowledge and general nucleic acid assay technology have moved koala immunological research a step closer to other mammalian research systems. However, koala-specific reagents to directly assay cytokine levels and cell-surface markers are still needed to progress our understanding of koala immunology. |
format | Online Article Text |
id | pubmed-7913230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79132302021-02-28 The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding Quigley, Bonnie L Timms, Peter Animals (Basel) Review SIMPLE SUMMARY: Chlamydia is a major pathogen of the Australian marsupial, the koala (Phascolarctos cinereus). One approach to improving this situation is to develop a vaccine. Human Chlamydia research suggests that an effective anti-chlamydial response will involve a balance between a cell-mediated Th1 response and a humoral Th2 responses, involving systemic IgG and mucosal IgA. Characterization of koalas with chlamydial disease suggests that increased expression for similar immunological pathways and monitoring of koalas’ post-vaccination can be successful and subsequently lead to improved vaccines. These findings offer optimism that a chlamydial vaccine for wider distribution to koalas is not far off. ABSTRACT: Chlamydia is a significant pathogen for many species, including the much-loved Australian marsupial, the koala (Phascolarctos cinereus). To combat this situation, focused research has gone into the development and refinement of a chlamydial vaccine for koalas. The foundation of this process has involved characterising the immune response of koalas to both natural chlamydial infection as well as vaccination. From parallels in human and mouse research, it is well-established that an effective anti-chlamydial response will involve a balance of cell-mediated Th1 responses involving interferon-gamma (IFN-γ), humoral Th2 responses involving systemic IgG and mucosal IgA, and inflammatory Th17 responses involving interleukin 17 (IL-17) and neutrophils. Characterisation of koalas with chlamydial disease has shown increased expression within all three of these major immunological pathways and monitoring of koalas’ post-vaccination has detected further enhancements to these key pathways. These findings offer optimism that a chlamydial vaccine for wider distribution to koalas is not far off. Recent advances in marsupial genetic knowledge and general nucleic acid assay technology have moved koala immunological research a step closer to other mammalian research systems. However, koala-specific reagents to directly assay cytokine levels and cell-surface markers are still needed to progress our understanding of koala immunology. MDPI 2021-02-03 /pmc/articles/PMC7913230/ /pubmed/33546104 http://dx.doi.org/10.3390/ani11020380 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Quigley, Bonnie L Timms, Peter The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding |
title | The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding |
title_full | The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding |
title_fullStr | The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding |
title_full_unstemmed | The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding |
title_short | The Koala Immune Response to Chlamydial Infection and Vaccine Development—Advancing Our Immunological Understanding |
title_sort | koala immune response to chlamydial infection and vaccine development—advancing our immunological understanding |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913230/ https://www.ncbi.nlm.nih.gov/pubmed/33546104 http://dx.doi.org/10.3390/ani11020380 |
work_keys_str_mv | AT quigleybonniel thekoalaimmuneresponsetochlamydialinfectionandvaccinedevelopmentadvancingourimmunologicalunderstanding AT timmspeter thekoalaimmuneresponsetochlamydialinfectionandvaccinedevelopmentadvancingourimmunologicalunderstanding AT quigleybonniel koalaimmuneresponsetochlamydialinfectionandvaccinedevelopmentadvancingourimmunologicalunderstanding AT timmspeter koalaimmuneresponsetochlamydialinfectionandvaccinedevelopmentadvancingourimmunologicalunderstanding |